T1	CHEM 46 57	vitamina D2
#1	AnnotatorNotes T1	C0014695; ergocalciferol; Organic Chemical · Pharmacologic Substance · Vitamin
T2	CHEM 60 71	vitamina D3
#2	AnnotatorNotes T2	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T3	CHEM 121 135	colecalciferol
#3	AnnotatorNotes T3	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T4	CHEM 137 139	D3
#4	AnnotatorNotes T4	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T5	CHEM 143 157	ergocalciferol
#5	AnnotatorNotes T5	C0014695; ergocalciferol; Organic Chemical · Pharmacologic Substance · Vitamin
T6	CHEM 159 161	D2
#6	AnnotatorNotes T6	C0014695; ergocalciferol; Organic Chemical · Pharmacologic Substance · Vitamin
T7	PHYS 454 469	posmenopáusicas
#7	AnnotatorNotes T7	C0206159; Postmenopause; Organism Function
T8	PROC 287 310	comparar la efectividad
T9	CHEM 328 330	D2
#8	AnnotatorNotes T9	C0014695; ergocalciferol; Organic Chemical · Pharmacologic Substance · Vitamin
T10	CHEM 393 413	25 hidroxivitamina D
#9	AnnotatorNotes T10	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T11	CHEM 341 343	D3
#10	AnnotatorNotes T11	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T12	PROC 1234 1250	niveles de 25OHD
#11	AnnotatorNotes T12	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
T13	PROC 569 597	asignadas en forma aleatoria
#12	AnnotatorNotes T13	C0034656; Randomization; Research Activity
T14	CHEM 706 711	25OHD
#13	AnnotatorNotes T14	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T15	PROC 720 723	RIA
#14	AnnotatorNotes T15	C0034580; Radioimmunoassay; Laboratory Procedure
T16	CHEM 849 856	25(OH)D
#15	AnnotatorNotes T16	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T17	ANAT 712 718	sérica
#16	AnnotatorNotes T17	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T18	PROC 697 718	Se midió 25OHD sérica
T19	CHEM 1073 1078	25OHD
#17	AnnotatorNotes T19	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T20	CHEM 1177 1188	vitamina D3
#18	AnnotatorNotes T20	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T21	CHEM 1210 1212	D2
#19	AnnotatorNotes T21	C0014695; ergocalciferol; Organic Chemical · Pharmacologic Substance · Vitamin
T22	PROC 20 34	suplementación
#20	AnnotatorNotes T22	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T23	CHEM 415 420	25OHD
#21	AnnotatorNotes T23	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T24	PROC 190 204	administración
#22	AnnotatorNotes T24	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T25	CHEM 1245 1250	25OHD
#23	AnnotatorNotes T25	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T26	CHEM 1321 1326	25OHD
#24	AnnotatorNotes T26	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T27	DISO 834 856	deficiencia de 25(OH)D
#25	AnnotatorNotes T27	C3279609; Low 25-OH-vitamin D level; Finding
T28	PROC 1137 1151	administración
#26	AnnotatorNotes T28	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T29	Frequency 35 41	diaria
T30	LIVB 75 90	adultos mayores
#27	AnnotatorNotes T30	C0001792; Elderly (population group); Population Group
T31	Date 219 230	actualmente
T32	Dose 314 320	800 UI
T33	Frequency 320 324	/día
T34	Form 332 337	gotas
#28	AnnotatorNotes T34	C0015399; Eye Drops; Biomedical or Dental Material
T35	Form 345 356	comprimidos
#29	AnnotatorNotes T35	C0039225; Tablet Dosage Form; Biomedical or Dental Material
T36	LIVB 446 453	mujeres
#30	AnnotatorNotes T36	C0043210; Woman; Population Group
T38	Age 534 549	77.1 ± 6.8 años
T39	Dose 644 650	800 UI
T40	Form 652 657	gotas
#31	AnnotatorNotes T40	C0015399; Eye Drops; Biomedical or Dental Material
T41	Dose 674 680	800 UI
T42	Form 682 693	comprimidos
#32	AnnotatorNotes T42	C0039225; Tablet Dosage Form; Biomedical or Dental Material
T43	Duration 744 763	los 7, 28 y 45 días
T44	LIVB 803 810	mujeres
#33	AnnotatorNotes T44	C0043210; Woman; Population Group
T45	Date 926 934	el día 7
T47	Duration 1156 1163	45 días
T48	Dose 1167 1173	800 UI
A1	Population_data T30 Age
T37	Neg_cue 1035 1038	sin
T46	Observation 1052 1078	valores adecuados de 25OHD
A2	Assertion T46 Negated
R1	Negation Arg1:T37 Arg2:T46	
R2	Has_Frequency Arg1:T1 Arg2:T29	
R3	Has_Frequency Arg1:T2 Arg2:T29	
R4	Experiences Arg1:T30 Arg2:T22	
R5	Used_for Arg1:T1 Arg2:T22	
R6	Used_for Arg1:T2 Arg2:T22	
R7	Used_for Arg1:T3 Arg2:T24	
R8	Used_for Arg1:T4 Arg2:T24	
R9	Used_for Arg1:T5 Arg2:T24	
R10	Used_for Arg1:T6 Arg2:T24	
R11	Has_Dose_or_Strength Arg1:T9 Arg2:T32	
R12	Has_Frequency Arg1:T9 Arg2:T33	
R13	Has_Drug_Form Arg1:T9 Arg2:T34	
R14	Has_Drug_Form Arg1:T11 Arg2:T35	
R15	Has_Frequency Arg1:T11 Arg2:T33	
R16	Has_Dose_or_Strength Arg1:T11 Arg2:T32	
R17	Experiences Arg1:T36 Arg2:T7	
R18	Has_Age Arg1:T36 Arg2:T38	
R19	Location_of Arg1:T17 Arg2:T18	
#34	AnnotatorNotes T18	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
R20	Overlap Arg1:T18 Arg2:T43	
R21	Overlap Arg1:T15 Arg2:T43	
T49	Quantifier_or_Qualifier 734 739	basal
#35	AnnotatorNotes T49	C1442488; Baseline; Quantitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T49	
R23	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T49	
R24	Experiences Arg1:T44 Arg2:T27	
T50	CONC 778 788	Basalmente
#36	AnnotatorNotes T50	C1442488; Baseline; Quantitative Concept
R25	Overlap Arg1:T27 Arg2:T50	
T51	CONC 938 948	incremento
#37	AnnotatorNotes T51	C0442805; Increase; Functional Concept
R26	Overlap Arg1:T51 Arg2:T45	
T52	CONC 975 982	aumento
#38	AnnotatorNotes T52	C0442805; Increase; Functional Concept
T53	CONC 1000 1017	final del estudio
R27	Overlap Arg1:T52 Arg2:T53	
R28	Overlap Arg1:T46 Arg2:T53	
R29	Overlap Arg1:T46 Arg2:T45	
R30	Used_for Arg1:T20 Arg2:T28	
R31	Has_Duration_or_Interval Arg1:T20 Arg2:T47	
R32	Has_Dose_or_Strength Arg1:T20 Arg2:T48	
R33	Used_for Arg1:T21 Arg2:T28	
R34	Has_Duration_or_Interval Arg1:T21 Arg2:T47	
R35	Has_Dose_or_Strength Arg1:T21 Arg2:T48	
T54	Quantifier_or_Qualifier 983 996	significativo
#39	AnnotatorNotes T54	C0750502; Significant; Idea or Concept
R36	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T54	
#40	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
#41	AnnotatorNotes T53	C2983670; Study End Date; Temporal Concept
#42	AnnotatorNotes T31	C0521116; Current (present time); Temporal Concept
A3	Experiencer T30 Patient
A4	Experiencer T36 Patient
A5	Experiencer T44 Patient
